Massimo Filippi1,2, Loredana Storelli1, Alessandro Meani1, Chiara Cervellin1, Paola Valsasina1, Claudio Cordani1, Elisabetta Pagani1, Paolo Preziosa1,2, and Maria A. Rocca1,2
1Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 2Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
Synopsis
Multiple sclerosis (MS) is a complex disease, characterized by a
highly heterogeneous disease evolution. The prognostic value of magnetic resonance
imaging (MRI) in clinically definite MS is still debated. The aim of this study
was to find possible structural and functional MR imaging prognostic biomarkers
able to guide treatment decisions in MS disease course. The analysis of
structural and functional MRI networks was able to improve our understanding of the extreme
variability in MS and allowed prognosis prediction at an individual level.
Introduction
In patients with
definite multiple sclerosis (MS), no reliable markers to predict medium- and
long-term disease evolution are currently available. The analysis of brain structural and functional network architecture
might improve the prediction of long-term MS prognosis. The aim of this study was
to assess the value of structural and functional network magnetic resonance
imaging (MRI) measures in predicting
clinical deterioration over a 6.5-year follow-up in patients with MS.Methods
Conventional, 3D T1-weighted, diffusion-weighted MRI and resting state (RS) fMRI scans
were obtained at baseline from 233 MS patients and 77 healthy controls. All patients
underwent a neurologic evaluation at baseline and after a
median follow-up of 6.5 years. At follow-up, patients were classified as clinically stable or worsened according
to Expanded Disability Status Scale (EDSS) score change. In relapsing-remitting
(RR) MS, conversion to secondary progressive (SP) MS was also evaluated. Spatial independent component analysis was applied
to RS fMRI data to derive the main large-scale RS functional connectivity (FC)
networks, as well as to grey matter (GM) probability maps and fractional
anisotropy maps, to identify the corresponding structural GM and white matter
networks.Results
At follow-up, 105/233
(45%) MS patients showed significant EDSS worsening and 26/157 (16%) RRMS
patients evolved to SPMS. The
multivariable model, adjusted for follow-up duration, identified baseline EDSS
(odds ratio [OR]=1.59, p<0.001), normalized GM volume (OR=0.99, p=0.001) and
abnormally high baseline RS FC of the left precentral gyrus in the sensorimotor
network (OR=1.67, p=0.03, Figure 1) as predictors of EDSS worsening (C-index=0.80,
Figure 2). Such variables survived also when adjusting for treatment effect
(Figure 3). Baseline EDSS (OR=2.8, p<0.001) and atrophy of GM networks
associated with sensory (OR=0.5, p=0.01) and motor (OR=0.4, p=0.03) functions were
independent variables associated with conversion to SPMS (C-index=0.89, Figure
4).Discussion
In this study, we found
that statistical models including clinical variables, conventional MRI metrics,
as well as structural and functional measures of sensorimotor network damage
were accurate in predicting which patients with MS had a disability worsening
or an evolution to a more severe phenotype over a six-year follow-up period.Conclusions
Structural and
functional network measures improved the prediction of long-term clinical
worsening in MS patients. The identification of biomarkers able to predict
disease worsening is of paramount importance to optimize patients’ treatments
in MS.Acknowledgements
Partially supported by grants from Fondazione Italiana Sclerosi Multipla (FISM2018/S/3). References
No reference found.